NL9002492A - Nieuwe bioafbreekbare injecteerbare microbolletjes, die geschikt zijn voor opneming in een geneesmiddel, werkwijze voor het bereiden van deze nieuwe microbolletjes en injecteerbare suspensies, die ze bevatten. - Google Patents

Nieuwe bioafbreekbare injecteerbare microbolletjes, die geschikt zijn voor opneming in een geneesmiddel, werkwijze voor het bereiden van deze nieuwe microbolletjes en injecteerbare suspensies, die ze bevatten. Download PDF

Info

Publication number
NL9002492A
NL9002492A NL9002492A NL9002492A NL9002492A NL 9002492 A NL9002492 A NL 9002492A NL 9002492 A NL9002492 A NL 9002492A NL 9002492 A NL9002492 A NL 9002492A NL 9002492 A NL9002492 A NL 9002492A
Authority
NL
Netherlands
Prior art keywords
radical
carbon atoms
microspheres
formula
hydrogen atom
Prior art date
Application number
NL9002492A
Other languages
English (en)
Dutch (nl)
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of NL9002492A publication Critical patent/NL9002492A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NL9002492A 1989-11-15 1990-11-15 Nieuwe bioafbreekbare injecteerbare microbolletjes, die geschikt zijn voor opneming in een geneesmiddel, werkwijze voor het bereiden van deze nieuwe microbolletjes en injecteerbare suspensies, die ze bevatten. NL9002492A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR898914976A FR2654337B1 (fr) 1989-11-15 1989-11-15 Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
FR8914976 1989-11-15

Publications (1)

Publication Number Publication Date
NL9002492A true NL9002492A (nl) 1991-06-03

Family

ID=9387417

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9002492A NL9002492A (nl) 1989-11-15 1990-11-15 Nieuwe bioafbreekbare injecteerbare microbolletjes, die geschikt zijn voor opneming in een geneesmiddel, werkwijze voor het bereiden van deze nieuwe microbolletjes en injecteerbare suspensies, die ze bevatten.

Country Status (13)

Country Link
JP (1) JPH03294229A (de)
AT (1) AT400298B (de)
BE (1) BE1005511A4 (de)
CA (1) CA2029940A1 (de)
CH (1) CH681691A5 (de)
DE (1) DE4036425A1 (de)
DK (1) DK270990A (de)
FR (1) FR2654337B1 (de)
GB (1) GB2239798B (de)
IT (1) IT1242010B (de)
LU (1) LU87836A1 (de)
NL (1) NL9002492A (de)
SE (1) SE9003570L (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
HU222501B1 (hu) * 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
ES2105525T3 (es) * 1993-06-24 1997-10-16 Lilly Co Eli 2-fenil-3-aroilbenzotiofenos antiestrogenicos como agentes hipoglicemicos.
US5910492A (en) * 1995-06-05 1999-06-08 Takeda Chemical Industries, Ltd. Osteogenic promoting pharmaceutical composition
EP2210585A1 (de) 2009-01-16 2010-07-28 Exelgyn Pharmazeutische SPRM-Zusammensetzungen, Behandlungsverfahren unter Anwendung dieser

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4293539A (en) * 1979-09-12 1981-10-06 Eli Lilly And Company Controlled release formulations and method of treatment
US4389330A (en) * 1980-10-06 1983-06-21 Stolle Research And Development Corporation Microencapsulation process
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
US4530840A (en) * 1982-07-29 1985-07-23 The Stolle Research And Development Corporation Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
FR2537980B1 (fr) * 1982-12-17 1986-12-19 Sandoz Sa Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation
ES8502612A1 (es) * 1983-06-15 1985-02-01 Schering Ag Procedimiento para la preparacion de 13a-alquilgonanos
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
FR2566779B2 (fr) * 1984-06-29 1987-03-06 Roussel Uclaf Nouveaux derives steroides substitues en 11b, leur procede de preparation et leur application comme medicaments
CA1256638A (en) * 1984-07-06 1989-06-27 Motoaki Tanaka Polymer and its production
FR2573657B1 (fr) * 1984-11-29 1989-05-12 Roussel Uclaf Produit comprenant une substance antiprogestomimetique et une substance uterotonique
DE3533175A1 (de) * 1985-09-13 1987-03-19 Schering Ag Antigestagene zur verschiebung der endometrialen reifung
FR2596395B1 (fr) * 1986-03-26 1989-05-26 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
DE3633244A1 (de) * 1986-09-26 1988-03-31 Schering Ag Antigestagene zur hemmung der uterinen prostaglandinsynthese
EP0310542B1 (de) * 1987-10-01 1994-06-08 Schering Aktiengesellschaft Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren
DE3733478A1 (de) * 1987-10-01 1989-04-13 Schering Ag Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
DE3744054A1 (de) * 1987-12-21 1989-06-29 Schering Ag Verwendung von antigestagenen zur herstellung von arzneimitteln
JP2785023B2 (ja) * 1987-12-30 1998-08-13 ルセル―ユクラフ １７α位置を置換された１７β―ＯＨ―１９―ノルステロイドの新誘導体、その製造方法、その薬剤としての使用及びそれを含有する製薬組成物
JP2670680B2 (ja) * 1988-02-24 1997-10-29 株式会社ビーエムジー 生理活性物質含有ポリ乳酸系微小球およびその製造法

Also Published As

Publication number Publication date
CA2029940A1 (fr) 1991-05-16
FR2654337B1 (fr) 1994-08-05
DK270990D0 (da) 1990-11-13
IT1242010B (it) 1994-02-02
LU87836A1 (fr) 1991-05-07
IT9048470A1 (it) 1992-05-13
ATA231390A (de) 1995-04-15
AT400298B (de) 1995-11-27
IT9048470A0 (it) 1990-11-13
SE9003570D0 (sv) 1990-11-09
CH681691A5 (de) 1993-05-14
GB9024862D0 (en) 1991-01-02
FR2654337A1 (fr) 1991-05-17
JPH03294229A (ja) 1991-12-25
GB2239798B (en) 1993-10-27
BE1005511A4 (fr) 1993-08-31
GB2239798A (en) 1991-07-17
SE9003570L (sv) 1991-05-16
DK270990A (da) 1991-05-16
DE4036425A1 (de) 1991-05-16

Similar Documents

Publication Publication Date Title
CN1288387A (zh) 缓释组合物、其制备方法及其应用
BG100632A (bg) Микрокапсулирани 3-пиперидинил-заместени 1,2- бензизоксазоли и 1,2-бензизотиазоли
NL9002492A (nl) Nieuwe bioafbreekbare injecteerbare microbolletjes, die geschikt zijn voor opneming in een geneesmiddel, werkwijze voor het bereiden van deze nieuwe microbolletjes en injecteerbare suspensies, die ze bevatten.
JP2002308850A (ja) 形態ｉｉの抗ヒスタミン性ピペリジン誘導体およびその製造方法
FR2484281A1 (fr) Procede de preparation de microspheres comportant un noyau solide et une matiere polymere
AU2006220742A1 (en) Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol and their use as estrogen receptor modulators
CN1237168A (zh) 双环芳基甲酰胺及其治疗应用
CZ304186B6 (cs) Krystalická forma I inhibitoru na bázi benzoxazinu a zpusob její výroby
CN1036521C (zh) 应用19-去甲甾族化合物的醇衍生物制备新的有机酸酯及其盐的方法
CH637397A5 (fr) Imidazobenzoxazines et leurs sels, procedes de preparation et compositions pharmaceutiques.
CN1104439C (zh) 苯基取代的4－氮杂甾族氟衍生物、其制备方法和用途及含有它们的药物组合物
US3013009A (en) Optionally 17-alkylated and 7-oxygenated androst (an and 5-en)-3-ol aminoalkyl esters and ethers
AU2008206599A1 (en) Pharmaceutically acceptable salts of 11- (4-aminophenyl) -19-n0rpregna-4,9 (10) -diene-3, 20-dione derivatives
EP0946585B1 (de) 11-substituierte steroid verbindungen, ein verfahren zu ihrer herstellung und medikamenten und pharmazeutische präparate davon
CH672887A5 (de)
EP0101383A1 (de) 14-Aminosteroidderivate, ihre therapeutische Anwendung und Verfahren zu ihrer Herstellung
WO1998028324A9 (fr) Steroides substitues en position 11, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
DE1720034A1 (de) Verfahren zur Herstellung von in 3-Stellung substituierten 2-Methyl-4(3H)-pteridinonen
CA2492079C (en) Microbiological processes for the production of 7 alpha-substituted 11 alpha-hydroxy steroids
EP1240156A1 (de) 3-methylchroman- oder thiochromanderivate
US20080132554A1 (en) Crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol
US20080176914A1 (en) Crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol
IE912539A1 (en) Novel derivatives of 6-methyl 19-NOR progesterone¹substituted in postion 3 and a process for their production
US3573285A (en) N-(3 - alkoxyestra - 1,3,5(10) - trien-17beta-ylamino)-tertiary amines and intermediates thereto
US3103505A (en) Y-dihydroxy-n-propyl

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BC A request for examination has been filed
BV The patent application has lapsed